4-phenylbutyric acid has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, YL; Lee, MY; Pui, NN | 1 |
1 other study(ies) available for 4-phenylbutyric acid and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetylation; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; DNA Damage; DNA Repair; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Immunoenzyme Techniques; Male; Mesocricetus; Mouth Neoplasms; Phenylbutyrates; Rad51 Recombinase; Radiation Injuries; Radiation Tolerance; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomatitis; Xenograft Model Antitumor Assays | 2009 |